Group 1 - The private placement completed on 16 September 2024 raised total gross proceeds of NOK 70 million [1] - The share capital increase related to the Tranche 2 shares has been registered, resulting in a new share capital of NOK 120,812,483.10 divided into 805,416,554 shares, each with a nominal value of NOK 0.15 [2] - Tranche 2 shares will be delivered on a separate and non-tradable ISIN, pending the publication of an approved prospectus by the Norwegian Financial Supervisory Authority [2] Group 2 - IDEX Biometrics ASA is a global technology leader in fingerprint biometrics, providing authentication solutions for payments, access control, and digital identity [3] - The company's biometric solutions are built on patented sensor technologies and target card-based applications for payments and digital authentication [3] - IDEX Biometrics partners with leading card manufacturers and technology companies to bring its solutions to market [3]

IDEX Biometrics ASA held an extraordinary general meeting on 9 October 2024. 112.2 million shares or 25.47% of the share capital was represented at the meeting. All proposals on the agenda were adopted in accordance with the proposals of the Company's board of directors, including the approval of Tranche 2 of the private placement, the subsequent offering and the warrants issuance, all as announced on 17 September 2024. For further information contact: Marianne Bøe, Head of Investor Relations E-mail: ir@ide ...

Reference is made to the notice on 25 September 2024 regarding issue of Tranche 1 shares of the private placement completed on 16 September 2024. The private placement consisted of two tranches, with total gross proceeds amounting to NOK 70 million. The share capital increase related to the Tranche 1 shares has been registered and the shares will be delivered soonest. The Tranche 1 shares will be delivered on a separate and non-tradable ISIN, pending publication by the Company of a prospectus approved by th ...

Reference is made to the announcement by IDEX Biometrics ASA (the "Company") on 17 September 2024 regarding the private placement of shares with gross proceeds of NOK 70 million (the "Private Placement"). The Company retained Arctic Securities AS as sole manager and bookrunner for the Private Placement (the "Manager"). The Private Placement is divided into two tranches. 101,624,966 shares were allocated in the first tranche ("Tranche 1" and the "Tranche 1 Offer Shares") and 365,041,700 Offer Shares were all ...

IDEX Biometrics ASA held an extraordinary general meeting on 23 September 2024. 87.2 million shares or 25.7% of the share capital was represented at the meeting. The authorisation to the board to issue new shares, was approved by the extraordinary general meeting. The board will apply this authorization to issue the Tranche 1 Shares as disclosed in connection with the private placement on 16 September 2024: https://newsweb.oslobors.no/message/627919 . For the avoidance of doubt, the issue of Tranche 2 Share ...

Correction: Replaced attachment. IDEX Biometrics ASA will hold an extraordinary general meeting on Wednesday 9 October 2024 at 12.00 hours CET as an online meeting. There is no physical attendance option. Shareholders may attend online. by PC, smartphone or tablet. Reference is made to the private placement of shares on 16 September 2024, disclosed to the market on that date. The board proposes that the shareholders shall approve issue of Tranche 2 shares, a subsequent repair offering, issue of Warrants, an ...

Company Overview - IDEX Biometrics ASA is a global technology leader in fingerprint biometrics, providing authentication solutions for payments, access control, and digital identity [3] - The company's biometric solutions are built on patented sensor technologies, integrated circuit designs, and software, targeting card-based applications for payments and digital authentication [3] - IDEX partners with leading card manufacturers and technology companies to bring its solutions to market, enhancing convenience, security, and user experience [3] Upcoming Events - An extraordinary general meeting will be held on 9 October 2024 at 12:00 CET as an online meeting, with no physical attendance option [1] - Shareholders can attend the meeting online via PC, smartphone, or tablet [1] Shareholder Proposals - The board proposes that shareholders approve the issuance of Tranche 2 shares, a subsequent repair offering, and the issuance of Warrants, along with authorizing the board to issue shares [2] - A notice with the attendance form will be sent to shareholders and is also available in a PDF file [2] Communication and Information Access - The notice of the annual general meeting and related documents are available on the company's website and can be requested at no charge [3] - For further inquiries, shareholders can contact the Head of Investor Relations, Marianne Bøe, via email or phone [3][4]

Core Viewpoint - IDEX Biometrics ASA has entered into a Commitment Letter with Heights Capital Management regarding amended terms for its senior convertible bond, contingent upon raising a minimum of NOK 60,000,000 from other investors [1][2]. Group 1: Company Actions - The Commitment Letter was officially executed on 17 September 2024, which includes the amended terms for the Convertible Loan [2]. - The implementation of the amended terms is dependent on the successful completion of a private placement announced on 16 September 2024 [2]. Group 2: Financial Details - The outstanding principal amount of the Convertible Bond is NOK 66,640,000 [1]. - The minimum gross proceeds required from other investors to activate the amended terms is NOK 60,000,000 [2]. Group 3: Company Overview - IDEX Biometrics ASA is a global leader in fingerprint biometrics, providing authentication solutions for payments, access control, and digital identity [4]. - The company focuses on card-based applications for payments and digital authentication, partnering with leading card manufacturers and technology firms [4].

Core Viewpoint - IDEX Biometrics ASA has successfully completed a private placement of new shares, raising gross proceeds of NOK 70 million, significantly oversubscribed, to support its commercialization and product development efforts [3][4]. Private Placement Details - The private placement raised NOK 70 million through the issuance of 466,666,666 new shares at a price of NOK 0.15 per share [3]. - The private placement is structured in two tranches: Tranche 1 includes 101,624,966 shares, and Tranche 2 includes 365,041,700 shares [5]. - Completion of Tranche 1 is subject to board authorization and an extraordinary general meeting (EGM I) on 23 September 2024, while Tranche 2 requires approval at a subsequent EGM II expected around 9 October 2024 [5][7]. Use of Proceeds - The net proceeds from the private placement will be allocated to commercialization efforts, product development, market development expenses, working capital needs, and general corporate purposes [4]. Warrants Issuance - Subscribers will receive two warrants for every two shares allocated, allowing them to subscribe for additional shares at the same offer price [6]. - Warrants A can be exercised within 14 days following the Q4 2024 financial report, while Warrants B can be exercised from 31 March 2025 to 11 April 2025 [6]. Settlement and Trading - Settlement for Tranche 1 is expected around 26 September 2024, and for Tranche 2 around 14 October 2024 [10]. - The shares are anticipated to become tradable on the Oslo Stock Exchange by the end of October 2024, pending the publication of an approved prospectus [11]. Subsequent Offering - A subsequent repair offering will be conducted for existing shareholders not allocated shares in the private placement, with a maximum amount of NOK 21 million [13]. - The offer price in the subsequent offering will match the private placement price, and oversubscription will be allowed [13]. Compliance and Equal Treatment - The private placement complies with equal treatment obligations under Norwegian law, allowing the company to raise capital efficiently at a 37.5% discount to the closing price on 16 September 2024 [12].

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Oslo, 16 September 2024. IDEX Biometrics ASA (the "Company"), a leading provider of advanced fingerprint identification and authentications solutions, has retained Arctic Securities AS as ...